Cite
HARVARD Citation
Merlano, M. et al. (n.d.). PD-033: Cetuximab + RT shows an excellent long term OS in patients with both high ADCC and high EGFR. Radiotherapy and oncology. pp. 19-20. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Merlano, M. et al. (n.d.). PD-033: Cetuximab + RT shows an excellent long term OS in patients with both high ADCC and high EGFR. Radiotherapy and oncology. pp. 19-20. [Online].